Apraxia contributes to the motor deficit in Parkinson's Disease and multiple system atrophy.
Swash
Michael
M
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001072:Apraxias / Q000150:complications* / Q000188:drug therapy; D015259:Dopamine Agents / Q000627:therapeutic use; D020820:Dyskinesias / Q000150:complications / Q000188:drug therapy; D006801:Humans; D019578:Multiple System Atrophy / Q000150:complications*; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy
D018726:Anti-Dyskinesia Agents; D015259:Dopamine Agents